Patents
Patents for C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
09/2000
09/05/2000US6114523 Process for the recycle of a waste product of diltiazem synthesis
09/05/2000US6114322 Anticholesterol agent
08/2000
08/30/2000CN1265109A Thiazolobenzoheterocycles, prepn. and medicines containing same
08/30/2000CN1265101A Crystalline dibentothiazepine derivatives and its use as antipsychotic agent
08/23/2000EP1029071A1 Process for preparing (2r,3s)-3-(4-lower alkoxyphenyl)glycidic acid esters
08/17/2000WO2000047568A2 1,2-benzothiazepines for the treatment of hyperlipidemic diseases
08/17/2000CA2362147A1 1,2-benzothiazepines for the treatment of hyperlipidemic diseases
08/09/2000EP1025080A1 Process for the recycle of a waste product of diltiazem synthesis
08/03/2000WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors
07/2000
07/26/2000EP1021190A1 Novel amide derivatives
07/20/2000WO2000042031A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
07/20/2000CA2359562A1 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
07/12/2000CN1054380C Condensed cyclic compounds and their use
07/06/2000WO2000038728A1 Combinations of ileal bile acid transport inhibitors and bile acid sequestring agents for cardiovascular indications
07/06/2000CA2356156A1 Combinations of ileal bile acid transport inhibitors and bile acid sequestring agents for cardiovascular indications
07/05/2000EP0686151B1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
06/2000
06/14/2000EP1007051A1 Integrin receptor antagonists
05/2000
05/17/2000EP1000067A1 Thiazolobenzoheterocycles, preparation and medicines containing same
05/17/2000EP1000043A1 A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent
05/17/2000CN1052479C Process for preparing 1,5-benzothiazepine derivatives
05/10/2000CN1252795A 4,1-benzoxazepines, their analogues,and their use as somatostatin agonists
04/2000
04/27/2000WO2000023416A1 New compounds, their preparation and use
04/13/2000WO2000020006A1 Use of diltiazem for treating retinal pathologies
04/12/2000CN1051226C Preparation of medicine for treating imbalance of memory and recognition with tri-cyclic compound
03/2000
03/30/2000WO2000017384A1 Process for the enzymatic kinetic resolution of 3-phenylglycidates by transesterification with aminoalcohols
03/29/2000EP0988297A2 Process for preparing optically active phenyloxirane compounds
03/28/2000US6043361 Polymerisable monomers and polymers
03/28/2000US6043358 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases
03/01/2000CN1245802A Preparation method of 1,5-benzothia azatropy lidene derivative
02/2000
02/23/2000EP0792268B1 Hypolipidemic benzothiazepines
02/16/2000EP0979227A1 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists
02/15/2000US6025506 Process for preparing an optically active phenylglycidyl acid derivative
02/15/2000US6025355 Substituted indolinyl and derivatives thereof, neurological injury and neurodegenerative disorders.
02/03/2000WO2000005246A1 Thioazepinone derivatives, preparation method and intermediates therefor, use as medicines and pharmaceutical compositions containing same
02/01/2000US6020330 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides
01/2000
01/19/2000CN1242007A Cycloalkyl, lactam lactone and related compounds as 'beta'-amyloid peptide release inhibitors
01/19/2000CN1048484C A process for preparing a composition containing benzoheterocycles
01/06/2000CA2330110A1 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors
12/1999
12/29/1999WO1999067230A1 INHIBITORS OF α4β1 MEDIATED CELL ADHESION
12/29/1999WO1999067219A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999WO1999066934A1 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
12/29/1999CA2342778A1 Inhibitors of .alpha.4.beta.1 mediated cell adhesion
12/29/1999CA2324475A1 Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds
12/29/1999CA2324474A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/28/1999US6008214 Inhibiting platelet aggregation and bone resorption, treating stroke, transient ischemia attacks, or myocardial infarction, treating osteoporosis
12/22/1999EP0964682A1 A method of treating liver disease and like indications with vasodilating agents
12/21/1999US6004948 Derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase II
12/16/1999WO1999063992A1 Novel calcium channel drugs and uses
12/16/1999CA2318901A1 Novel calcium channel drugs and uses
12/07/1999US5998637 Process for preparing optically active trans-3-substituted glycidic acid ester
12/07/1999US5998400 Atherosclerosis
11/1999
11/18/1999WO1999058531A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999CA2330108A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/16/1999US5985869 Benzoheterocyclic compounds
11/03/1999CN1233957A Pharmaceutical compositions
10/1999
10/27/1999EP0951466A2 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
10/20/1999CN1232457A 1,4-heterocyclic metalloprotease inhibitors
10/19/1999US5968924 Benzo-fused lactams promote release of growth hormone
10/13/1999CN1231661A Aralkyl and aralkylidene heterocyclic lactams and imides
10/12/1999US5965553 Anticholesterol agents, hypotriglyceridemic agents, antiatherosclerosis agents, antifungal agents, alzheimer's agents or anti-acne agents
10/06/1999EP0946180A1 Method for stimulating bone formation
09/1999
09/15/1999CN1228773A Heterocyclic metalloprotease inhibitors
09/15/1999CN1228772A Heterocyclic metalloprotease inhibitors
08/1999
08/31/1999US5945533 Process for preparing optically active benzothiazepine compound and intermediate therefor
08/18/1999CN1226164A Method for treating liver disease and like indications with vasodilating agent
08/17/1999US5939412 Bicyclic fibrinogen antagonists
08/12/1999WO1998008505A8 Pharmaceutical compounds
08/11/1999EP0934065A1 Pharmaceutical compounds
08/04/1999EP0933354A1 Calcium receptor-active compounds
08/04/1999CN1225083A Calcium receptor-active compounds
07/1999
07/27/1999US5929069 Compounds activating pharmacological effects of retinoids
07/27/1999US5929068 Intermediates for preparing diltiazem can be readily obtained without using an expensive optically active resolving agent
07/21/1999EP0929528A1 Aralkyl and aralkylidene heterocyclic lactams and imides
07/21/1999CN1044238C Method for preparing benzylidene derivatives
07/15/1999WO1999035135A1 Hypolipidemic benzothiazepine compounds
07/15/1999CA2317651A1 Hypolipidemic benzothiazepine compounds
06/1999
06/30/1999EP0925300A1 Pharmaceutically active compounds and methods of use
06/30/1999EP0925287A1 Heterocyclic metalloprotease inhibitors
06/23/1999EP0923563A1 1,4-heterocyclic metallprotease inhibitors
06/23/1999EP0923561A1 Heterocyclic metalloprotease inhibitors
06/22/1999US5914332 Retroviral protease inhibiting compounds
06/08/1999US5910494 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides
05/1999
05/06/1999WO1999022014A1 Process for preparing (2r,3s)-3-(4-lower alkoxyphenyl)glycidic acid esters
05/04/1999CA2150766C Method for the manufacture of benzothiazepine derivatives
04/1999
04/29/1999WO1999020603A1 Process for the recycle of a waste product of diltiazem synthesis
04/29/1999CA2304371A1 Process for the recycle of a waste product of diltiazem synthesis
04/27/1999CA2087743C Pharmaceutical composition for inhibiting platelet aggregation
04/15/1999WO1998038182A9 Hypolipidemic bicyclic derivatives
04/14/1999EP0626952B1 Hypolipidaemic benzothiazepine compounds
04/07/1999EP0906907A1 Compounds potentiating retinoid
03/1999
03/30/1999US5888542 Matrix tablet allowing the prolonged release of the sodium salt of tianeptine after administration by the oral route
03/25/1999WO1998056762A3 Process for preparing optically active phenyloxirane compounds
03/16/1999US5883264 Subjecting racemic trans-3-phenylglycidamide compound to optical resolution using a microorganism having ability of preferentially hydrolyzing one of (2s,3r) isomer or (2r,3s) isomer thereof
03/09/1999US5880295 Process for the preparation of diamine intermediates useful in the synthesis of HIV protease inhibitors
03/04/1999WO1999009991A1 Novel amide derivatives
03/04/1999CA2301566A1 N-acylated lipophilic amino acid derivatives
03/02/1999US5877170 Substitute caprolactams and derivatives thereof useful for treatment of HIV disease
02/1999
02/18/1999WO1999007875A1 Process for preparing (2r,3s)-3-(substituted or unsubstituted phenyl)glycidamide compounds by asymmetric amidation
02/17/1999CN1208405A Retroviral protease inhibiting compounds
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20